Fairvalue-Calculator Fairvalue-Calculator
EN DE

InspireMD, Inc (NSPR) Fair Value & Analysis

Healthcare · US · Market cap $33.3M

Price$0.7001
Fair Value$1.01
Upside+44.3%
Quality95/100
Evidence: Low Range $0.6700 – $1.26

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

InspireMD, Inc (NSPR) currently trades at $0.7001, while our model-based Fair Value estimate is $1.01 — implying the stock looks roughly 44.3% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions. The company was founded in 2005 and is headquartered in Miami, Florida.

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -23% Stryker Corporation (S1YK34) -89% Medtronic plc (MDT) -7% Boston Scientific Corporation (B1SX34) -81% Edwards Lifesciences Corporation (EW) -53% Siemens Healthineers AG (SEMHF) +19%

Frequently asked questions

Is InspireMD, Inc (NSPR) undervalued?
As of Jun 25, 2026, our model estimates a fair value of $1.01 versus a price of $0.7001 — about +44% (undervalued). Model-based estimate, not financial advice.
What is the fair value of NSPR?
Our 21-model fair value for InspireMD, Inc is $1.01 (as of Jun 25, 2026), built from audited fundamentals. The current price is $0.7001.
What is the quality score of NSPR?
InspireMD, Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.